Dr David Wayne Carter, PHARMD, RPH, PD in Chetopa, KS - Pharmacist

Dr David Wayne Carter, PHARMD, RPH, PD is a Pharmacist based in Chetopa, Kansas. Dr David Wayne Carter is licensed to practice in Kansas (license number 1-13008) and his current practice location is 330 Locust, Chetopa, Kansas. He can be reached at his office (for appointments etc.) via phone at (620) 236-7272.

NPI number for Dr David Wayne Carter is 1346357993 and his current mailing address is Po Box 92, Chetopa, Kansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1346357993.

Contact Information

	Dr David Wayne Carter, PHARMD, RPH, PD
	330 Locust, Chetopa, KS 67336
	(620) 236-7272
	(620) 236-7395

Healthcare Provider's Profile

Full Name	Dr David Wayne Carter
Gender	Male
Speciality	Pharmacist
Location	330 Locust, Chetopa, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1346357993
Provider Enumeration Date: 08/23/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr David Wayne Carter such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1346357993	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	1-13008 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr David Wayne Carter is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr David Wayne Carter, PHARMD, RPH, PD Po Box 92, Chetopa, KS 67336-0092 Ph: (620) 236-7812	Dr David Wayne Carter, PHARMD, RPH, PD 330 Locust, Chetopa, KS 67336 Ph: (620) 236-7272

News Archive

Fighting NCDs can be achieved with low-cost interventions

In this Atlantic opinion piece, Amanda Glassman, director of Global Health Policy at the Center for Global Development (CGD), and Denizhan Duran, a research assistant at CGD, outline the macro- and microeconomic effects non-communicable diseases (NCDs) can have on countries and families, noting that "80 percent of NCD deaths occur in developing countries, mostly the middle-income countries."

Dendritic cells as a new player in arteries and heart valves

In 1973, Ralph M. Steinman launched a new scientific discipline when he published his discovery of the dendritic cell, an odd-shaped player in the immune system.

Horizon Medicare beneficiaries to receive pharmacy services through Prime Therapeutics

Beginning January 1, 2014, Horizon Healthcare Services, Inc. Medicare beneficiaries will receive pharmacy services through Prime Therapeutics LLC. Prime began providing pharmacy benefit management services to the plan's commercial members July 1, 2013.

Spouses face hurdles when caring for themselves, ill loved ones

Reporting for Kaiser Health News, in collaboration with The Washington Post, Paula Span writes: "They met on a blind date in 1949 and married two years later.

Merrimack receives $2.44 million under QTDP program to support cancer research

Merrimack Pharmaceuticals was awarded $2.44 million to support research on 10 of its cancer programs through the Qualifying Therapeutic Discovery Project, a grant program created as part of the Patient Protection and Affordable Care Act of 2010 to advance research in areas of unmet medical need.

Dr David Wayne Carter, PHARMD, RPH, PD - Pharmacist in Chetopa, KS